PUBLISHER: Allied Market Research | PRODUCT CODE: 1139938
PUBLISHER: Allied Market Research | PRODUCT CODE: 1139938
The global interventional oncology market size is expected to reach up to $3,791.50 million by 2030, surging from $2,131.30 million in 2021, at a noteworthy CAGR of 6.5%.
Interventional oncology (IO) is an emerging specialty that focuses on using image-guided procedures (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care. Due to an increase in cancer cases among people worldwide, the interventional oncology market is expected to accelerate its expansion over the forecast period. Cancer is one of the fastest rising health problems in the world, impacting people of all ages, from infants to the elderly. Breast cancer and throat cancer are two of the most common types of cancer in people. The need for technologically improved cancer management therapy has expanded in tandem with the rise in the number of cancer patients. This aspect is predicted to contribute to the market's positive expansion in the following years. However, because interventional oncology therapy is a relatively new branch of treatment, its market penetration is low, and few people are aware of it.
The global interventional oncology market is segmented on the basis of product type, cancer type, and end user. On basis of product type, the market has been divided into embolization devices, ablation devices, and support devices. Based on cancer type, the market has been divided into liver cancer, lung cancer, bone metastasis, kidney cancer, breast cancer, prostate cancer, and other cancers. Based on end-user, the market has been categorized into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the leading interventional oncology market players are Medtronic, Boston Scientific, BD, Terumo, Merit Medical, AngioDynamics, J&J, Teleflex, Cook Medical, and HealthTronics.
By Product Type
By Cancer Type
By End User
By Region
By Product
By Region